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Abstract Ion channels and transporters play a critical role
in ion and fluid homeostasis and thus in normal animal
physiology and pathology. Tight regulation of these
transmembrane proteins is therefore essential. In recent
years, many studies have focused their attention on the role
of the ubiquitin system in regulating ion channels and
transporters, initialed by the discoveries of the role of this
system in processing of Cystic Fibrosis Transmembrane
Regulator (CFTR), and in regulating endocytosis of the
epithelial Na+ channel (ENaC) by the Nedd4 family of
ubiquitin ligases (mainly Nedd4-2). In this review, we
discuss the role of the ubiquitin system in ER Associated
Degradation (ERAD) of ion channels, and in the regulation
of endocytosis and lysosomal sorting of ion channels and
transporters, focusing primarily in mammalian cells. We
also briefly discuss the role of ubiquitin like molecules
(such as SUMO) in such regulation, for which much less is
known so far.
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Introduction
Ion channels play a major role in regulation of the
electric properties of virtually every cell. Because of
their capability to allow the passage of more than 106
ions per second across a membrane, their activity and
expression at the plasma membrane is tightly regulated by
a plethora of different cellular mechanisms. In recent years
it has become evident that the ubiquitin system plays a
major role in this control [3]. The modification of target
proteins with ubiquitin often (although not always) targets
them for degradation by the proteasome or lysosomes [67,
177], and is now recognized as a critical mechanism for
regulation of many cellular functions. Ubiquitin is a 76
amino acid long polypeptide, which becomes conjugated
via an isopeptide bond on the ε amino groups of lysine.
This is achieved by an enzymatic cascade, involving an
E1 (ubiquitin-activating) enzyme, an E2 (ubiquitin-
conjugating) enzyme, and an E3 ubiquitin-protein ligase.
E3 enzymes provide the specificity to the cascade, as they
recognize the relevant target proteins and promote the
conjugation of ubiquitin. The process is reversible and
involves the activity of deubiquitylating (DUB) enzymes.
The two major E3 classes known are RING E3s that
facilitate transfer of ubiquitin from an E2 to substrates,
and Hect E3s, which directly bind ubiquitin and transfer it
onto the substrate. In mammals, there are over 1000 E3
enzymes and over 100 DUBs. Different types of ubiquitin
modifications can be generated: Ubiquitin can be conju-
gated as a mono-ubiquitin on a lysine residue. However,
frequently poly-ubiquitin chains are generated that link
ubiquitins via internal lysines present in ubiquitin. Indeed,
it is now known that polyubiquitin chains are formed that
can involve any of the lysines on ubiquitin (K6, K11, K27,
K29, K33, K48, K63) [218, 223] and hence largely increase
D. Rotin (*)
Program in Cell Biology, The Hospital for Sick Children
and Biochemistry Department, University of Toronto,
Toronto, Canada
e-mail: drotin@sickkids.ca
O. Staub (*)
Department of Pharmacology and Toxicology,
University of Lausanne,
Lausanne, Switzerland
e-mail: Olivier.staub@unil.ch
Pflugers Arch - Eur J Physiol (2011) 461:1–21
DOI 10.1007/s00424-010-0893-2
the amount and versatility of ubiquitylation. Moreover, a
number of ubiquitin-like (UBL) proteins have been discov-
ered that modify proteins. Similar, but not identical enzymatic
cascades are involved in UBL's conjugation, with the final
outcome often not resulting in protein degradation. In this
review we summarize the role of the ubiquitin system and
UBLs in the regulation of ion channels and transporters both
during their processing and their endocytosis and sorting
(Table 1).
Role of the ubiquitin system in regulating ion channels
in ER/Golgi
The ERAD system
Proteins destined for the secretory pathway and plasma
membrane proteins are inserted co-translationally into the
endoplasmic reticulum (ER) membrane, representing ap-
proximately one third of all newly synthesized proteins
[141]. In the ER, these proteins are subject to regulation by
the quality control system, ensuring that proteins fold
properly or multimeric complexes assemble correctly.
Proteins that do not, are recognized, retrotranslocated into
the cytosol, ubiquitylated and degraded by the proteasome,
a process known as ER associated degradation (ERAD). As
is evident, the nature of the many client proteins is very
diverse (soluble proteins, mono- or polytopic membrane
proteins, protein complexes), and consequently the machin-
ery is complex. Misfolded or unassembled proteins are
recognized by chaperones [143], chaperone-like lectins
[29], or protein disulfide isomerase homologues [201].
They assist with folding the client proteins and release them
either for ER export or for ERAD (if folding/assembly
fails). Proteins are then transferred to secondary quality
control machinery, which includes the ubiquitin-protein
Table 1 Ion channels and transporters regulated by the ubiquitin system
Transport protein Cellular function
of ubiquitylation
Involved enzymes and proteins of the ubiquitin
pathway
References
ENaC ERAD Doa10, Hrd1p [26]
CFTR/ΔF508-CFTR ERAD/Endocytosis RMA1, CHIP, gp78, SCFFbs [137, 139, 146, 229]
ENaC Endocytosis, recycling Nedd4-2, UBE2E3, Usp2, Usp10,
UCH-L3
[2, 23, 27, 42, 54, 99, 191]
NavS, Nav1.2, Nav1.3, Nav1.5,
Nav1.7, Nav1.8
Endocytosis Nedd4-2, Nedd4/Nedd4-like proteins [61, 170, 204]
KCNQ1/KCNE1 Endocytosis Nedd4-2 [95]
KCNQ2/3, KCNQ3/5 Endocytosis Nedd4-2 [50, 175]
KCNA3/KCNA5 Endocytosis Nedd4-2 [17, 79]
CACNB1 Endocytosis Nedd4-2 [155]
TRPV4, TRPC4 Endocytosis AIP4/Itch [213]
TRPV6 Endocytosis Nedd4-2 [232]
ClC5 Endocytosis WWP2, Nedd4-2 [84, 176]
ClC2 Endocytosis Nedd4-2 [150]
ClC-Ka/Barttin Endocytosis Nedd4-2 [51]
TTHY2 Endocytosis Nedd4-2 [77]
EAAT2 Endocytosis Nedd4-2 [17]
DMT1 Endocytosis Nedd4-2/Ndfip1 [59, 83]
ASIC Endocytosis Parkin/Pick1 [96]
AQP2 Endocytosis ? [98]
PC1, PC2 Sorting to lysosome ? [85]
PC2 Degradation by proteasome SCFβ-Trcp [198]
ROMK1 Endocytosis POSH [123]
Gap1 Endocytosis Rsp5/Bul1 or Bul2 [189]
Smf1, Smf2 Endocytosis Bsd2 [124]
Connexin 43 Endocytosis Nedd4-2 [115]
TRPM4 Endocytosis SUMO [110]
K2P1 Intrinsic activity SUMO [161]
Kv2.1 Intrinsic activity SUMO [40]
Kv1.5 Intrinsic activity SUMO [11]
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ligases Hrd1 [107] and its homologue gp78 [35]. Hrd3 and
SEL1L associate with Hrd1 and contribute to ERAD
substrate processing [121, 140]. Derlin-1, -2 and -3,
possibly with Sec61, have been suggested to form the
retrotranslocation channel in the ER membrane, and the
p97-Ufd1-Npl4 complex assists with “retrotranslocating”
and delivering the proteins to the proteasome [121, 145,
160, 227, 228]. Ubiquitylation may take place during or
after retrotranslocation. A number of additional ubiquitin-
protein ligases can participate in ERAD, including Doa10
[196], RMA1 [139], CHIP (in combination with Hsp70)
[137] or SCFfbs ligases [229].
ERAD of transmembrane proteins
The quality control of transmembrane proteins in the ER is
a challenging task, as these proteins have three topologi-
cally distinct regions that have to be monitored to ensure
that the folding of the protein is correct: extracellular,
transmembrane and intracellular domains. Consequently, it
has been proposed that there are three different types of
ERAD mechanisms with respect to transmembrane proteins
[33, 196, 206]. ERAD-C (cytoplasmic pathways) monitors
and recognizes the cytoplasmic regions of the protein (as is
the case for the Cystic Fibrosis Transmembrane Regulator
(CFTR) channel, where the cytoplasmic Hsp70/CHIP act;
see below), whereas the ERAD-L system detects luminal
folding defects (with the help of Bip, calnexin/calyculin,
OS-9, XTP3-B and others). Alternatively membrane pro-
teins and especially multimeric transmembrane protein
complexes may have folding defects in the membrane-
spanning region, qualifying these as ERAD-M class of
molecules. These pathways have been primarily character-
ized in yeast [33], where different ERAD complexes with
different E3 ubiquitin-protein ligases play a role. It is
currently believed that at least in yeast, ERAD-C substrates
require Doa10, whereas ERAD-L and ERAD-M substrates
require the Hrd1p ubiquitin-protein ligase. In mammalian
cells it is likely that other ligases are involved as well. It is
possible that depending on the nature of the protein several
of these mechanisms are implicated in parallel, as seems to
be the case for CFTR (see below). There is evidence for a
large number of multimeric transmembrane complexes and
channels whose assembly is controlled by ER and which
involve ERAD. Examples include the T-cell receptor [19,
226], the nicotinic acetylcholine receptor [38, 207],
GABAA receptors [71], voltage-gated Na
+ channels [174],
connexin 32 [205], NMDA receptors [104, 190], K+-
channels [65, 132, 133, 179, 199, 224, 231], Ca2+-channels
[209], Inositol 1,4,5-triphosphate receptors [211, 219] and
ENaC [103, 202]. The mechanisms by which these proteins
are recognized by ERAD vary widely, including intra-
membrane charges [19], C-terminal PDZ binding motifs
[190, 199], or positive charges in the cytoplasmic domains
[231]. It is becoming clear that these events can be
regulated. This is the case for KCNK3 channels, in which
14-3-3 binding to phosphorylation sites can overcome the
ER retention by dibasic signals [144], the IP3 receptors
which become degraded upon stimulation, an event that
involves the ERAD protein SPFH2 [154], or Kv1.2 K-
channel in which phosphorylation plays a role in ER exit
[224]. Here, we discuss two selected examples, namely the
quality control and ERAD of CFTR, which is one of the
best characterized transmembrane ERAD substrate, and
ENaC, which is an example of a multimeric transmembrane
protein assembled in the ER (Fig. 1).
CFTR as a model for integral membrane proteins subjected
to ERAD
The cystic fibrosis transmembrane regulator (CFTR) is the
gene product responsible for cystic fibrosis (CF) when
mutated [167]. The large interest into ERAD of this multi-
membrane spanning protein is due to a mutant CFTR
(CFTRΔF508), which is present approximately in 90% of
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Fig. 1 Chaperones and ubiquitin-protein ligases involved in ERAD of
CFTR and ENaC. a ER associated degradation of CFTR. On the
cytosolic side, Hsp40, Hsp70 and Hsp90, as well as αA-crystallin
(cryst), are involved in recognition of the unfolded cytosolic regions,
whereas calnexin is involved in luminal control. Hsp70 recruits the
ubiquitin-protein ligase CHIP. Other ubiquitin-protein ligases are also
involved, such as Gp78, Hrd1p/Der3, Doa10, as well as the cytosolic
RMA1 and SCF(Fbx). b The ERAD machinery for the 2-TM domain
ENaC subunits is less well characterized, and possibly less complex.
The heatshock proteins Hsp70/Hsc70, Hsp40 and αA-crystallin have
been shown to play a role, as well as Doa10 and Hrd1p/Der3
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all Caucasian CF patients, and which represents a folding
mutant that is retained in the ER and degraded by ERAD
[109]. Indeed, it was one of the first ERAD substrates to be
shown to be degraded in a ubiquitin-dependant fashion
by the proteasome [93, 210]. CFTR is a member of the
ATP binding cassette (ABC) transporter superfamily and
contains 1,480 amino acids. It is composed of two
membrane spanning domains (with six transmembrane
(TM) each), two cytosolic nucleotide binding domains
(NBD1 and NBD2), and a regulatory R region. The
assembly of this protein into a functional ion channel is
complex, as the different domains have to be folded in a
coordinated fashion, whereby they are thought to interact
in a co- and post-translational fashion. The complexity of
this process is illustrated by the fact that only 25% of the
wild-type channel are properly folded and exported to the
cell surface, whereas the rest is degraded via ERAD; in the
case of CFTRΔF508 the entire pool is degraded by ER
[37]. As with other proteins chaperones (Hsp40, Hsp70,
Hsp90, αA-crystallin, calnexin) [5, 233] contribute to the
recognition of CFTR by ERAD, as do lectins [147].
ERAD involves the participation of various complexes,
such as Derlin-1, either to retain CFTR in the ER
membrane or to serve as retrotranslocon, and promoting
the interaction with the ubiquitin-protein ligase RMA1
that acts in concert with the E2 enzyme Ubc6e [139]. It is
believed that RMA1 is capable of recognizing folding
defects in CFTR in a co-translational fashion, whereas
CHIP, another E3 ligase, appears to interact together with
Hsp70 in a post-translational manner with misfolded
NBD2 [137]. Other ubiquitin-protein ligases are also
important, such as gp78 [139], or SCFFbs [229]. As well,
the extracting activity of p97/Ufd1/Npl4 is necessary for
CFTR degradation [68].
ENaC, an example of a multimeric protein controlled
by ERAD
The amiloride-sensitive epithelial Na+ channel (ENaC) is
composed of three subunits, αβg, and is expressed
primarily in the apical membrane of salt-absorbing
epithelia, such as those in the distal nephron, distal colon
and lung [47], where it participates it salt and fluid
absorption (see below). It is well established that efficient
functional expression of this channel at the cell surface
requires all three subunits [28, 57, 87, 135, 136]. αβ and
αg dimers are also able to generate small amiloride-
sensitive currents, whereas βg channels are rather weakly
expressed at the cell surface [20]. Study of such “dimeric”
channels is important for both physiological and patho-
physiological reasons. ENaC is highly regulated by the
steroid hormone aldosterone, which positively regulates
this channel. At least in the kidney, this is achieved by
regulating the expression level of αENaC; without
aldosterone stimulation αENaC is expressed at only very
low levels; under such conditions the β and g subunits are
retained in an as yet undefined compartment [126, 134].
Aldosterone stimulation leads to αENaC expression,
assembly with the βg subunits and translocation of the
channel to the plasma membrane [126]. It is not
understood how and where the βg dimmers are retained,
and how they are protected from degradation. Moreover,
there is a pathological condition, pseudohypoaldosteron-
ism type I, in which mutations in the genes encoding
either α-, β- or gENaC lead to inactivation of these
subunits, leaving the cell with only two subunits [34]. As
for many other multimeric membrane complexes it is
believed that the ENaC channel subunits assemble in the
ER and are exported to the plasma membrane, and that at
least part of the unassembled subunits are retained in the
ER and eventually degraded by ERAD. It is not clear how
subunits assemble but they do so early in biosynthesis,
possibly prior to glycosylation. It was shown earlier that
the N-terminus of gENaC plays a crucial role in channel
assembly [4], that each subunit can interact with each
other to form dimers, and that multiple ENaC domains
participate in its assembly [25]. Processing/assembly of
ENaC is inefficient, with less than 1% of synthesized
subunits reaching the plasma membrane [202, 214],
suggesting that the bulk of newly synthesized proteins
are eliminated by ERAD. Little is known how unassem-
bled ENaC chains are retained in the ER, and how they are
targeted for ERAD. No ER retention signal has been
identified, but a C-terminal exit signal was characterized
recently [103]. Beside the fact that ENaC needs to
assemble all three subunits in order to be efficiently
targeted to the cell surface, the evidence (sometimes
indirect) for ERAD of ENaC subunits is as follows: (1)
Intracellular ENaC subunits are polyubiquitylated [13, 23,
54, 90, 130, 171, 192, 234], whereas ENaC at the cell
surface appears to be either mono- or multi-mono-
ubiquitylated [171, 216]. (2) Proteasome, but not lyso-
somal inhibition, interferes with turnover of individually
expressed ENaC subunits in MDCK cells, whereas the
turnover of ENaC subunits in cells expressing all three
subunits is inhibited by both inhibitors. This implies that
there are 2 populations of ENaC subunits in such cells,
assembled ones (multi-mono-ubiquitylated) that traffic to
the plasma membrane and later to the lysosomes, and the
unassembled ones (polyubiquitylated) that are degraded
by ERAD and the proteasome [192]. (3) It has been shown
that proteasome inhibition can increase ENaC activity in
A6 cells, most likely by inhibiting ERAD of ENaC
subunits, and increasing the level of unassembled sub-
units, consequently increasing the chance of channel
assembly in the ER [129]. Recently, some light has been
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shed on the machinery that appears to be involved in
ERAD. First, it has been shown that Hsp70, a stress-
induced protein, and Hsc70 (a constitutively expressed
Hsp70 paralogue), both cytosolic chaperone involved in
ER quality control, play an important role in ENaC
regulation [69]. Interestingly, when co-expressed in
Xenopus laevis oocytes, Hsp70 stimulates cell surface
expression of ENaC, whereas Hsc70 decreases it. This
difference is not very well understood, but it suggests that
Hsc70 targets ENaC for ERAD, whereas Hsp70 may
promote its folding. The same group also identified αA-
crystallin as a protein involved in ERAD [103]. Similar to
what was done for CFTR, αENaC was expressed in yeast
cells, and its turnover tested in various mutants, including
Hsp26 and Hsp42 mutants, in which the protein was
stabilized. It was then shown that αA-crystallin (the
Hsp26 orthologue) reduces ENaC activity and cell surface
expression when co-expressed in Xenopus oocytes. Evi-
dence was provided that it was the delivery pathway to the
plasma membrane (i.e. secretory pathway) that was
involved and not the endocytic pathway. Recently, the
expression of ENaC subunits in yeast cells has led to
additional characterization of the ERAD mechanisms
involved in ENaC degradation [26]. It was shown that
singly expressed ENaC subunits display several defects in
different compartments (cytosolic, luminal and possibly
membrane), as evidenced by the observation that both
Doa10 (a ubiquitin-protein ligase important for cytosolic
substrates), as well as Hrd1p (luminal and membrane
regions) were required for turnover of the ENaC subunits.
Moreover, it was shown that luminal Hsp40 proteins
(Jem1 and Scj1), but not Bip (a luminal Hsp70 chaper-
one), were involved in turnover and ubiquitylation of
ENaC. This was further supported in Xenopus oocytes, in
which the Hsp40 orthologue ERdj3 and ERdj4 inhibited
amiloride-sensitive currents [26]. However, it remains to
be seen if these mechanisms are also valid in more
physiological cells, such as renal epithelia.
Role of the ubiquitin system in endocytosis, sorting
and recycling of ion channels and transporters
The role of ubiquitin in endocytosis and sorting of
transmembrane (TM) proteins has received much attention
over the past 15 years, initially from work in yeast [64, 78,
82] and in mammalian cells [114, 191]. Relevant to this
review, our initial observation that ENaC binds the Nedd4/
Nedd4-2 family of E3 ligases [191] opened the field to
many subsequent studies that have focused on the role of
ubiquitin system, and in particular the Nedd4 family
proteins, in the regulation of cell surface stability and
endocytosis of ion channels and transporters in mammals.
Regulation of ENaC by Nedd4-2
Perhaps the best-studied example of the regulation of ion
transport by ubiquitin is that of ENaC regulation by Nedd4-
2. As indicated above, ENaC regulates salt and fluid
absorption in epithelia of several organs, including kidney,
lung and colon. The critical role of ENaC in salt and fluid
absorption in these tissues/organs is underscored by the
findings that loss or gain of function mutations in this
channel in humans causes pseudohypoaldosteronism Type I
(PHAI) or pseudoaldosteronism (Liddle syndrome- see
below), respectively, diseases that are also recapitulated in
mouse models bearing the same mutations [89, 120]. In the
kidney, ENaC function is up-regulated by the hormone
aldosterone, which binds the mineralocorticoid receptor
(MR), while in the lung it is up-regulated by glucocorti-
coids and their cognate receptor (GR) [125]. As indicated
above, ENaC is comprised of 3 subunits, αβg [28], with a
short proline-rich sequence, called the PY motif (PPxYxxØ,
minimal consensus = L/PPxY), present at the cytosolic C-
terminus of each subunit [173, 187, 191]. The PY motif of
β or g ENaC is deleted or mutated in Liddle syndrome [74,
75, 120, 183], a hereditary hypertension caused by
increased activity and number of ENaC channels at the
plasma membrane [57]. These PY motifs serve as binding
sites for Nedd4 proteins [191], in particular Nedd4-2 [2, 76,
99, 188]. Nedd4-2 (Nedd4L) possesses a C2 domain that
can be spliced out [92], 4 WW domains that bind PY motifs
[102, 191], and an E3 ligase Hect domain. The third WW
domain, present in all Nedd4-2 but absent in most Nedd4-1
proteins (except human, zebrafish and Drosophila Nedd4-1),
appears to provide higher affinity interactions to PY motifs
[80, 101], but both WW3 and WW4 of Nedd4-2 are essential
for interaction with and regulation of ENaC [60, 92, 100]. It
is curious that human Nedd4-1, which also possesses 4 WW
domains including WW3, can only inhibit ENaC function
upon removal of its inhibitory C2 domain [100, 185], in line
with a recent demonstration of inhibition of Hect catalytic
activity by the C2 domain of the Nedd4 family relative
Smurf2 [217] and Nedd4-1 and -2 [208], which in the latter
can be relieved by elevated Ca2+ levels. However, it should
be emphasized that the data with Nedd4-1 have been
acquired in heterologous expression systems; to date there
is no in vivo evidence that endogenous Nedd4-1 is involved
in ENaC regulation.
Given the ability of Nedd4-2 to interact with the PY
motifs of ENaC, which are deleted/mutated in Liddle
syndrome, it was proposed [191] and later demonstrated
[2, 99] that the increased retention of channels at the plasma
membrane in this disease may be caused by impaired
ubiquitylation and endocytosis of the mutant channels
(Fig. 2a). Indeed, ENaC's cell surface stability was shown
earlier to be negatively regulated by ubiquitylation on its α
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and g subunits [192]. In support, recent studies have
demonstrated that Nedd4-2 can ubiquitylate ENaC at the
plasma (apical) membrane [127, 216, 234]. Moreover, the
increased retention of the PY motif mutant ENaCs at the
plasma membrane is primarily caused by impaired inter-
nalization of the mutant channels, with some defects also
observed in channel sorting and cAMP-dependent mobili-
zation of channels from a sub-apical pool [127]. The nature
of ENaC ubiquitylation is not entirely clear, but several
reports recently suggested that the channel is mono or
multi-mono ubiquitylated at the cell at the cell surface [171,
216, 234], a finding that is in accord with the known role of
mono or oligo-ubiquitylation in endocytosis and sorting of
transmembrane proteins [81]. Another group proposed that
native ENaC in A6 cells is regulated by polyubiquitylation
and is degraded by the proteasome [129, 130] although it
needs to be established whether the polyubiquitylated pool
is the one at the plasma membrane. The type of ubiquitin
linkage employed is not known, but one would expect to
identify at least some K63-linked ubiquitylation of ENaC, a
linkage often detected in proteins destined for endosomal
sorting and lysosomal degradation, and was described in
transmembrane proteins that are target for Rsp5 (the yeast
Nedd4 orthologue)—mediated ubiquitylation and endocy-
tosis/sorting [63, 111, 149]. In addition to regulating cell
surface stability, the PY motifs (Nedd4-2 binding sites) of
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with ENaC. U ubiquitin
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ENaC also regulate its response to intracellular Na+
concentrations, since feedback inhibition by Na+ exhibited
by WT ENaC is inhibited in a PY motif mutant of the
channel [45, 106, 151].
The clear prediction from these findings is that the
increased retention of active ENaC at the plasma membrane
would increase Na+ reabsorption in the kidney, leading to
hypertension, as seen in Liddle syndrome patients. Indeed,
knock-in mice bearing the Liddle syndrome mutation in
βENaC exhibit salt-induced hypertension, metabolic alka-
losis and hypokalemia, leading to renal and cardiac
hypertrophy which resembles the human Liddle disease
[159]. In accord, these Liddle mice exhibit enhanced
alveolar fluid clearance following pulmonary edema
[162]. Interestingly, recently generated knockout (KO) mice
of Nedd4-2 exhibit a similar phenotype, with salt-induced
hypertension (which was inhibited by amiloride) and
cardiac hypertrophy, suggesting upregulation of ENaC.
Indeed, ENaC protein expression in the kidney of these
mice was elevated, and rectal PD measurements indicated
excessive ENaC activity also in their colon [181]. While the
potential effect of loss of Nedd4-2 on lung function of these
KO mice was not described, a separate study using RNAi to
knockdown Nedd4-2 in rat lungs immediately after birth,
which led to ~60% reduction in level of Nedd4-2, has
demonstrated increased ENaC expression along with
reduced extravascular lung water following knockdown
[116]. This suggests that Nedd4-2 suppresses ENaC
function in the lung, similar to its function in the kidney
and colon.
It has long been recognized that CFTR regulates ENaC
function, in most cases leading to inhibition of ENaC
activity by reducing its open probability [194]. In cystic
fibrosis (CF), where CFTR is defective, Na+ and fluid
absorption is elevated, leading to dehydration of airway
surface fluid, mucus accumulation and repeated bacterial
infections [22, 46]. Recent work by Mall, Boucher and co-
workers provided further support for this model, by
demonstrating that overexpression of ENaC (βENaC) in
mouse airways leads to a CF-like phenotype, a process that
can be ameliorated by treatment of the mice with amiloride
[131, 235]. An important issue that needs to be addressed
is, therefore, why do Liddle syndrome patients, exhibiting
excessive ENaC activity, not develop CF-like disease?
The elevated blood pressure (BP) in the Nedd4-2 KO
mice suggests that mutations or variation in the NEDD4-2
gene in humans may be involved in the regulation of blood
pressure [168]. In support, a recent study suggested that a
cryptic splice variant (generated by the SNP rs4149601)
that generates Isoform I of Nedd4-2 (NEDD4-2 A allele,
aka Nedd4-2C8 [48]) is associated with hypertension in a
Chinese group of patients [128]. This splice isoform, which
generates an inactive protein [48], was proposed to interact
with other Nedd4-2 isoforms and block their function in a
dominant negative fashion, thus leading to enhanced ENaC
activity [8]. Another variant, encoding NEDD4-2-P355L,
was shown to be less effective at suppressing ENaC than
the native protein, likely due to its enhance phosphorylation
[62] (see below).
Role of Nedd4-2 in hormone-mediated regulation of ENaC
As indicated above, aldosterone and vasopressin (ADH), as
well as insulin, enhance ENaC function. In search for
transcripts and proteins that exhibit early response to
aldosterone and glucocorticoids, several groups identified
serum and glucocorticoid- regulated kinase 1 (Sgk1), a
relative of Akt (PKB) [212]; Sgk1 was shown to enhance
ENaC function by stimulating an increase in ENaC
abundance at the plasma membrane in response to
aldosterone, including in renal collecting ducts [7, 36,
126, 142, 182]. Subsequent work, initially from Staub and
co-workers, demonstrated that Sgk1 phosphorylates Nedd4-
2 on Ser residues (S444, S338), a process that involves a
PY motif present in Sgk1 and suggests a Nedd4-2:Sgk1
interaction (most likely of low affinity [80, 163]); This
phosphorylation leads to interference with the ability of
Nedd4-2 to interact with ENaC, resulting in increased
abundance of channels at the plasma membrane, as
demonstrated in a Xenopus oocyte model system, tissue
culture cells and cortical collecting ducts [41, 58, 186]
(Fig. 2b). Unlike Nedd4-2, Nedd4-1 does not possess Sgk
phosphorylation sites, and is not known to be regulated by
aldosterone. In addition to Sgk1, it appears that cAMP-
activated PKA can also phosphorylate Nedd4-2, on the
same sites as those used by Sgk1, leading to increased
ENaC abundance due to its inability to interact with
phosphorylated Nedd4-2 [184]. Since cAMP is generated
and PKA activated in response to vasopressin release and
its binding to its V2 receptor, these collective results
suggest that Sgk1 and PKA serve as convergent points to
phosphorylate Nedd4-2 and block its ability to suppress
ENaC in response to both aldosterone and vasopressin
(Fig. 2b), the two major hormones regulating fluid
absorption, blood volume and BP.
In addition to the regulation of Sgk/PKA/Nedd4-2 by
aldosterone and vasopressin, Insulin was recently shown to
increase ENaC function by activating its downstream
effectors Akt1 and Sgk1, thus feeding into the same
Nedd4-2 pathway and connecting cellular metabolism and
growth to ENaC [112]. Likewise, Il-1β—induced cortisol
production was shown to stimulate fluid absorption (ENaC
activation) via Sgk-mediated Nedd4-2 inhibition in fetal
guinea pigs lungs [117]. Additionally, the WNK kinase was
also shown to activate Sgk1, resulting in suppression of
Nedd4-2 and elevated ENaC function [222]; mutations in
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WNK cause PHAII, a form of hypertension. Interestingly,
another player, IkappaB kinase β (IKKB), was recently
shown to phosphorylate Nedd4-2 on S444 (the same site as
that phosphorylated by Sgk1), leading to enhanced accu-
mulation and function of ENaC at the plasma membrane
[49]. These latter results provide another arm to the
regulation of ENaC by Nedd4-2, connecting it to inflam-
mation and the immune system (Fig. 2b).
How does phosphorylation of Nedd4-2 by Sgk/PKA
prevent it from interacting with ENaC? Recent studies
identified 14-3-3 proteins as binding partners to phosphor-
ylated Nedd4-2; 14-3-3 maintains phosphorylated Nedd4-2
in a “blocked” form that cannot bind ENaC [13, 90].
Recent work also suggested that a heterodimer of the 14-3-
3β:14-3-3ε is required for this interaction [118] and that
these 14-3-3 isoforms are themselves induced by aldoste-
rone [119]. The exact mechanism of this “blockage” is still
unknown, since the phosphorylation sites on Nedd4-2 are
located outside the WW domains that bind the PY motifs of
ENaC; it is possible that a 14-3-3 dimer binds to Nedd4-2
and alters its conformation, thus masking the binding sites
on its WW domains. This, however, remains speculative
until the structure of Nedd4-2 in complex with the PY
motifs of ENaC, in the presence or absence of 14-3-3, is
solved.
While the Sgk1/Nedd4-2 pathway can lead to enhanced
ENaC function, it should be kept in mind that aldosterone,
vasopressin and Sgk1 can also activate ENaC independent-
ly of Nedd4-2. Evidence for this is provided by the
observations that (1) aldosterone and Sgk1 can increase
cell surface levels of ENaC channels bearing the Liddle
syndrome mutations (which cannot properly bind Nedd4-2)
[7, 9, 43, 182], (2) Cortical collecting tubules harvested
from mice bearing the Liddle syndrome mutation reveal
normal response to aldosterone [39], (3) ENaC activity in
the colon of these Liddle mice is enhanced by aldosterone
[12], and (4) ENaC was shown to be inhibited by WNK4
kinase, a process inhibited by Sgk1, which phosphorylates
WNK4 [165, 166].
Interestingly, recent reports provide a connection be-
tween ENaC and the metabolic state of the cell, by
demonstrating that the metabolic sensor AMP kinase
(AMPK) inhibits ENaC function in a PY motif-dependent
manner, by enhancing its ability to interact with Nedd4-2,
thus reducing cell surface stability of the channel [6, 14, 30]
(Fig. 2c); the latter effect did not involve Sgk or PKA, and
overall suggests that under metabolic stress, reducing ENaC
function by activated AMPK, leading to enhanced channel
endocytosis, would prevent cellular Na+ overload. Like-
wise, Erk (part of the MAPK pathway) downregulates
ENaC by phosphorylating it on Thr residues in the C
termini of β and g ENaC, thus facilitating ENaC interaction
with Nedd4/Nedd4-2 [138, 180, 225], although it is not
clear yet how such phosphorylation would increase ENaC:
Nedd4/Nedd4-2 binding given the hydrophobic nature of
WW domain:PY motif interaction [101, 102].
Two knockout models of Sgk1 have been generated and
the role of Sgk1 in ENaC regulation has been evaluated in
these mice. Wulff et al. found that Sgk1 (−/−) mouse
displayed a salt-losing phenotype only when mice were
kept under low Na+ diet. Under such conditions, ENaC was
also weakly expressed, as evidenced by potential difference
(PD) measurement in isolated cortical collecting ducts and
by immunohistochemistry [221]. Somewhat different data
were obtained by Fejes-Toth et al. Although they also found
a salt-losing phenotype under low Na+ diet, they observed
by in situ patch clamping CCD cells that amiloride-
sensitive Na+ currents were upregulated under these
conditions, suggesting that other Na+ transporters must be
upregulated, including the thiazide-sensitive Na+/Cl-co-
transporter [55]. Hence the precise role of Sgk1 in vivo in
the kidney remains to be further characterized, and the
mechanism of aldosterone regulation continues to remain
obscure.
De-ubiquitylating enzymes and ENaC
The critical role of the E3 ubiquitin ligase Nedd4-2 and
ubiquitylation in the regulation of ENaC endocytosis and cell
surface stability prompted a search for de-ubiquitylation
enzymes (DUBs) that may participate in this regulation as
well. Recently, a DUB induced by aldosterone, Usp-45, was
identified by Verrey and colleagues [54]. Usp-45 deubiquity-
lates ENaC and stimulates ENaC cell surface stability and
function; this effect is dependent on the presence of the PY
motifs of ENaC and on its prior ubiquitylation by Nedd4-2,
but is independent of Sgk1 [54]. Another DUB that was
described to regulate ENaC is the endosomal DUB,
UCH-L3 [27]. UCH-L3 increases cell surface expression
of ENaC by de-ubiquitylating it, presumably in an endo-
somal compartment, and enhancing its recycling to the
plasma membrane. Given the known role of cAMP in
inducing ENaC recycling [127], it would be interesting to
test whether UCH-L3 participates in this process. In
addition, the DUB Usp10 was recently identified as a
transcript/protein whose expression is elevated following
vasopressin stimulation, an increase that leads to enhanced
ENaC abundance and function at the plasma membrane
[23]. Usp-10 utilizes an adapter protein, SNX3, to carry
out its effect on ENaC, as detailed below.
Thus, specific DUBs appear to oppose the action of
Nedd4-2 (directly, or indirectly via an adapter protein),
leading to increased ENaC stabilization at the plasma
membrane (Fig. 3), especially in response to hormones that
are released into the blood stream to promote ENaC
function and Na+/fluid absorption.
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Relationship between regulation of ENaC ubiquitylation
and its proteolytic cleavage
Proteolytic cleavage of the ectodomain of ENaC by serine
proteases leads to activation of the channel by increasing its
open probability (Po) [88, 169, 203]. In particular, the α
and g subunits are the targets for such cleavage: αENaC is
cleaved by Furin at two site, releasing an inhibitory peptide/
tract, whereas gENaC is cleaved by Furin at one site and by
anther protease, such as prostasin/CAP1, elastase or
plasmin, at a second site, to promote release of the
inhibitory tract [24, 31, 32, 86, 153]. It appears that the
inhibitory tract provide higher affinity for Na+ [178] and
may mediate the well-known self-inhibition of ENaC by
extracellular(luminal) Na+ [151]; thus, removal of the
inhibitory tract by proteases promotes channel activation
(increased Po) by decreasing sensitivity to luminal Na+
[178]. Curiously, while proteases increase ENaC Po, their
effect is connected to ubiquitylation, Nedd4-2 and Usp-45.
Work from Snyder and colleagues has demonstrated that
Nedd4-2 facilitates rapid endocytosis of proteolytically
cleaved ENaC, leading to increased degradation of the
cleaved, active channel [97]. This endocytosis was depen-
dent on the presence of the PY motifs of ENaC. In accord,
mutations of these PY motifs (mimicking those in Liddle
syndrome) or mutation of the ubiquitin acceptors sites in
ENaC increased the fraction of cleaved, active channels at
the plasma membrane [108]. In agreement with these
observation, Staub and colleagues have recently demon-
strated that Usp-45—mediated de-ubiquitylation of ENaC
enhances its proteolytic cleavage (on α and g ENaC), thus
stimulating its activation [171]. These data thus suggest that
ubiquitylation may regulate the conformation of the
extracellular domain, and likely the accessibility of protease
sites for cleavage.
The strong reliance of ENaC on Nedd4-2-mediated
downregulation (channel ubiquitylation and endocytosis)
has been a long-standing puzzle, since intuitively it would
be much faster to close the channel rather than to inernalize
it when its function is no longer needed; the recent findings
that protease cleavage releases a segment of the channel
(the inhibitory tract), leading to irreversible opening of the
channel, helps explain this puzzle, since such constitutively
active channels have to be removed from the plasma
membrane to stop the influx of Na+.
Regulation of endocytosis of other ion channels by Nedd4
family ubiquitin ligases
Following the discovery of ENaC: Nedd4/Nedd4-2 inter-
actions, several groups have identified PY motifs in
numerous other channels, prompting investigations into
their potential regulation by Nedd4 proteins, as described
below.
Voltage-gated Na+channels
Voltage-gated Na+ channels, Navs, are responsible for
generating action potential in excitable cells, primarily in
cardiac and neuronal tissues. They are comprised of pore-
forming α subunits assembled together with regulatory β
subunits [230]. These channels play a critical role in cardiac
and neuronal functions, and mutations in some of them
cause human diseases [230]. For example, mutations in
Nav1.5 (SCN5A) that impair its inactivation in the heart lead
to long QT (type 3) and Brugada syndromes [105] and
inactivation of the Scn5a gene in mice leads to cardiac
function defects [152]. Likewise, gain of function mutations
in Nav1.1 (SCN1A) causes generalized epilepsy with febrile
seizures (GEFS+) by enhancing inward Na+ current in brain
neurons [52]. Of the ten known Navs, seven (Nav 1.1–1.3
and Nav1.5–1.8) possess a conserved PY motif (PPSYxxØ)
at the cytosolic C termini of their α subunits [61, 170].
Much like ENaC, cell surface stability of the cardiac Nav1.5
was demonstrated to be negatively regulated by Nedd4-2, a
process that requires the PY motif of this channel, as well
as active Nedd4-2, suggesting channel ubiquitylation
regulates its endocytosis [1, 204]. Similar results were
obtained for other PY-motif containing Navs, Nav1.2, 1.3,
1.7 and 1.8 [61, 170]; while Nedd4-2 was the predominant
E3 ligase involved in suppressing these Navs, WWP2 and
Nedd4-1 may contribute to the regulation as well. A recent
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Fig. 3 Opposing actions of E3 ligases and DUBs on channel
abundance at the cell surface. a Ubiquitin ligases such as Nedd4-2
ubiquitylate ion channels (e.g., ENaC) at the plasma membrane,
leading to its endocytosis. This action can be opposed (b) by de-
ubiquitylating enzymes (DUBs), such as USP2-45 or UCH-L3, which
remove ubiquitins from the channel, thus increasing its cell surface
abundance by promoting recycling (e.g., bin the case of UCH-L3) or
possibly by decreasing endocytosis. U ubiquitin
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search for NEDD4-2 variants in ~250 families with
photosensitive generalized epilepsy (IGE) identified several
such variants, although their expression in Xenopus oocytes
did not affect their ability to interact with Nav1.2, nor alter
channel function [44], suggesting that the physiological
significance of these variants need to be further explored.
Recently it was shown that Nav1.6 is regulated by
Nedd4-2 as well. Interestingly Nedd4-2 appears to interact
with 2 motifs, one of which is a PGSP motif that needs to
be phosphorylated by the p38 kinase in order to interact
with Nedd4-2 [66].
Voltage-gated K+channels and Ca2+ channels
Voltage-gated K+ channels comprise several subfamilies,
including the KCNQ (Kv7), KCNA (Kv1), KCNB (Kv2)
and others. These channels play a key role in neuronal
excitability, and mutations in several of them cause
neurological and cardiac impairments. For example, loss
of function mutations in KCNQ2 (Kv7.2) or KCNQ3
(Kv7.3) cause epilepsy [164], while such mutations in
KCNQ1 (Kv7.1) or its associated subunit KCNE1 cause
Long QT (Type I) syndrome (cardiac ventricular arrhyth-
mia) [105].
KCNQ1 possesses a PY motif (LPxYxxØ) at its
intracellular C terminus, which is conserved across species
and serves as binding site for human Nedd4-2, Nedd4-1, or
WWP2. Accordingly, the current produced by the KCNQ1/
KCNE1 channel (Iks) is reduced by overexpression of these
Nedd4 family members and is suppressed by their
catalytically inactive mutants, or upon mutating the PY
motif of KCNQ1 [95]. These Nedd4 family members thus
affect channel ubiquitylation and internalization. Likewise,
the muscarinic-sensitive K+ current (M-current), mediated
by heterotetrameric channels consisting of KCNQ3 associ-
ated with either KCNQ2 or KCNQ5 (i.e., KCNQ2/3 or
KCNQ3/5), are regulated by Nedd4-2, ubiquitylation and
Sgk1 [50, 175]. The C termini of KCNQ2 and KCNQ3
contain an atypical “PY motif” (PPxPPY). However, while
Nedd4-2 can bind the C termini of these channel subunits,
binding is not mediated via this motif [50]; thus, Nedd4-2
either interacts with another C-terminal sequence, or via an
adapter protein. Active Nedd4-2 is required to suppress
function of these channels, suggesting that ubiquitylation
regulates their stability, likely at the cell surface [50].
Similar to ENaC, the regulation of KCNQ2/3 and KCNQ3/
5 via Nedd4-2 can be modulated by Sgk1 mediated
phosphorylation of this E3 ligase [175].
The K+ channels Kv1.3 (KCNA3) and Kv1.5 (KCNA5),
which are stimulated by insulin or IGF-1, have been
demonstrated to be inhibited by Nedd4-2 and up-regulated
by Sgk1, which suppresses Nedd4-2, using Xenopus oocyte
expression system [17, 79]. Nedd4-2 was shown to
ubiquitylate Kv1.5, thus inducing its endocytosis [17].
Interestingly, while Kv4.3 (KCND3) assembled with its
accessory protein KChiP, was stimulated by Sgk1, this
stimulation was not mediated via Nedd4-2 and was not
associated with increased cell surface stability of this
channel [10].
In addition to the above-described examples, a recent
proteome array screen aimed at identifying substrates for
mammalian Nedd4 protein, identified other K+ channels as
in vitro substrates for Nedd4-2: KCNAB1, KCNAB3 and
KCNB1 (Kv2.1), with the latter two possessing PY motifs
[155]. The role of these in vitro substrates needs to be
examined in vivo now to test if these channels are regulated
by Nedd4-2 in a physiological setting.
The same proteome array screen also identified the Ca2+
channel, CACNB1, as a substrate for Nedd4-2, an
observation that was also validated in mammalian cells
[155]. Interestingly, a subset of the TRP Ca2+ channel, such
as TRPV4 and TRPC4, have been shown to be ubiquity-
lated and AIP4/Itch, a Nedd4-like protein; this ubiquityla-
tion leads to endocytosis of these channels [213], thus
suppressing their function. This AIP4—mediated ubiquity-
lation requires the N terminal region of the TRP channels,
although a variant PY motif (GPxYxxL) present within the
N-terminus was dispensable [213]. Recently, evidence was
also provided that the calcium channel TRPV6 may be
regulated by Nedd4-2 [232].
Collectively, these results point to a major role of Nedd4
proteins, primarily Nedd4-2, in promoting ubiquitylation
and endocytosis of numerous cell surface cation channels,
thus suppressing their function.
Cl− channels/transporters
Much like cation channels, several anion channels have
been shown to be regulated by Nedd4 family members,
with Cl- channels (ClC) family most extensively studied.
The ClC family comprises both Cl− channels and Cl−/H+
antiporters [94, 215]. ClC5 is a Cl−/H+ antiporter that is
expressed primarily in endosomal membranes in the
proximal tubules and is responsible for endosomal acidifi-
cation, a role it carries out in collaboration with V-ATPase.
This acidification is required for re-absorption of small
molecule proteins, minerals and vitamins by the kidney
[72]. Loss of function mutations in CLC5 leads to Dent
disease, a disorder characterized by excessive loss of
proteins (proteinuria), calcium and phosphate in the urine,
resulting in kidney stones [220]. In accord, ClC5 knockout
mice exhibit proteinuria and defects in both receptor
mediated and fluid phase endocytosis, resembling Dent
disease in humans [156]. A carboxy terminal PY motif
(PPLPPY) was identified earlier in ClC5, and shown to be
required for endocytosis of the channel [176]. It was
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postulated that WWP2 could be mediating the endocytosis
of ClC5 by interacting with its PY motif [176], although a
later study proposed that Nedd4-2 is the E3 ligase involved
[84]. In the latter study, Nedd4-2 was shown to regulate
ClC5 ubiquitylation and albumin uptake into endosomes.
Similar to ClC5, ClC2 was also shown to be regulated by
Nedd4-2 [150]. ClC2, a bone fide Cl− channel, is
ubiquitously expressed and is localized to the plasma
membrane. Disruption of ClC2 in mice causes testicular
and retina degeneration, as well as wide-spread vacuolation
in the white matter of the CNS, suggesting that regulation
of ionic environment via ClC2 in these cells/tissues is
necessary for their normal maintenance [16, 21]. One study
also suggested that the ClC2 gene is included in a
chromosomal region associated with susceptibility to
epilepsy [172], however, the putative role of ClC2 in this
increased susceptibility needs to be further investigated.
ClC2 was shown to be positively regulated by Sgk1-3, and
negatively regulated by Nedd4-2, which reduces it cell
surface expression [150], although a direct interaction
between Nedd4-2 and ClC2 was not demonstrated in that
study, nor does ClC2 possess a PY motif. ClC-Ka is
another bone fide Cl− channel that along with ClC-Kb is a
basolateral channel expressed in the ascending loop of
Henley and regulates Na+, Cl−, and fluid absorption. In
accord, knockout of Clck1 (ClC-Ka) in mice leads to severe
urinary loss [200]. The ClC-Ka and ClC-Kb channels
require co-expression of an accessory protein, barttin, to
become functional [53]. Mutations in BSND (the barttin
gene) causes a severe form of Bartter’s syndrome, charac-
terized by severe renal salt wasting and deafness [15].
Interestingly, Barttin contains a PY motif and its mutation
enhances activity of the ClC-Kb/Barttin channel [53]. It
was subsequently shown that Nedd4-2 can suppress ClC-
Ka/Barttin function when co-expressed in Xenopus oocytes,
an effect prevented upon mutation of the PY motif in
barttin [51]. Here, too, Sgk1 and Sgk3 were able to
phosphorylate Nedd4-2 and block its suppression of the
channel.
In addition to the ClC family, other Cl− channels appear
to be regulated by Nedd4 proteins. The Tweety (TTYH)
family are maxi Cl− channels that includes three members
in humans, TTYH1-3, with TTYH2 and TTYH3 (but not
TTYH1) activated by Ca2+ [195]. TTYH2 and TTYH3
possess a PY motif, which a recent study has suggested is
involved in binding to Nedd4-2; accordingly, Nedd4-2 was
shown to ubiquitylate TTYH2 and regulate its cell surface
stability [77]. An additional Cl− channel, CLIC2 (intracel-
lular Cl− channel 2), could potentially be another target for
regulation by Nedd4-2, as it was identified in the above-
described proteome array screen as a target for ubiquityla-
tion by Nedd4-2 (and Nedd4-1) and possesses a PY motif
[155].
The suppression of channel function by Nedd4 family
members was also reported in several transporters in
addition to ClC5. For example, the excitatory amino acid
transporter EAAT2 (which does not contain a PY motif)
was shown to be suppressed by Nedd4-2 and stimulated by
Sgk1-3 or Akt [18]. Likewise, the divalent metal transport-
er, DMT1, was shown to be regulated by WWP2 and
Nedd4-2; this was mediated by recruitment of the adapter
protein Ndfip1 [59, 83], as described below. Moreover the
connexin 43, which contains a PY-motif, was also demon-
strated to be regulated by Nedd4-2 [115] by one group,
whereas the Staub's group found that the extened PY-motif
was rather part of a tyrosine-based sorting signal not
regulated by Nedd4 ubiquitin-protein ligases [197].
In addition to the regulation of CFTR and its ΔF508-
CFTR trafficking mutant by ERAD in the biosynthetic
pathway (described above), it was recently found that
“rescued” ΔF508-CFTR that is able to reach the plasma
membrane exhibits a short half life there and is targeted for
degradation by the E3 ligase CHIP, with the aid of several
chaperones and co-chaperones [146].
Overall, it appears that cell surface stability of numerous
ion channels and transporters is regulated by Nedd4
proteins, mainly Nedd4-2 (and sometimes WWP2, Nedd4-1,
or AIP4). This regulation often involves the Sgk/Akt
family of kinases, which phosphorylate Nedd4-2 thus
preventing it from interacting with its targets. The
regulation by these kinases (and others) help link
Nedd4-2 and the channels its ubiquitylates to hormone
and growth factors signaling (e.g. aldosterone, vasopres-
sin, insulin), which play critical roles in maintaining
homeostasis of ion and fluid composition and overall
normal physiological functions of the organism.
Regulation of endocytosis of channels/transporters
by other (or unknown) E3 ligases
While most studies to date have focused on the
regulation of ion channels/transporters by Nedd4 family
proteins, several others have described regulation of such
channels by different (or still unknown) E3 ligases. For
example, function of the ENaC-related channel, ASIC, is
suppressed by the E3 ligase Parkin, in a process that
includes the adapter protein, PICK1 [96] (see below).
Another example is the water channel AQP2, which is
oligo-ubiquitylated with ub(K63) on one Lys residue upon
withdrawal of vasopressin/forskolin or PKC activation,
which targets it for endocytosis, MVB sorting and
lysosomal degradation [98]. The E3 ligase that mediates
this reaction is not yet known.
In cilia of the mammalian kidney and sensory cilia in
Caenorhabditis elegans, polycystin-1 (PC1, encoded by
PKD1) and PC2 (TRPP2, encoded by PKD2) function
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together as a mechanosensory Ca2+ channel. Using C.
elegans, it was recently shown that this channel complex
is sorted for lysosomal degradation by the STAM-Hrs
system in a process that involves mono-ubiquitylation of
PC2 by as yet an unknown E3 ligase [85]. The
physiological importance of these channels and their
regulation is underscored by the observation that muta-
tions in PKD1 or PKD2 cause autosomal dominant
polycystic kidney disease (ADPKD), an end stage renal
disease [91]. In a separate study, it was discovered that
knockout of the transcription factor TAZ in mice led to
increased levels of PC2 [198]; upon phosphorylation, TAZ
interacts with SCFβ-Trcp to form an E3 ligase complex,
which then targets PC2 for degradation by the proteasome
[198]. It is unlikely that the TAZ:SCFβ-Trcp complex (and
polyubiquitylation) is also involved in targeting of the
PC1:PC2 channel for sorting by STAM-Hrs and lysosomal
degradation, and thus suggests that regulation of this Ca2+
channel is mediated by more than one E3 ligase. In
addition to regulation by E3 ligases, a role for DUBs was
also described for the regulation of TRP channels. The
TRPA1 channel, which responds to cold temp and pungent
compounds, was shown to associate with the DUB CYLD,
which is a tumor suppressor; this leads to de-
ubiquitylation of TRPA1 and its stabilization, thus
connecting TRPA1 to oncogenesis [193].
Analogous to regulation of several K+ channels by
Nedd4 family members (described above), a recent paper
describes the suppression of ROMK1 (Kir1.1) by the RING
E3 ligase POSH [123]. POSH binds the N terminus of
ROMK1, leading to channel ubiquitylation via the POSH-
RING domain and endocytosis via a clathrin-independent
pathway [123].
Ubiquitin-mediated regulation of ion channels
and transporters via adapter proteins
In most of the examples described above, Nedd4-2 (or its
family relatives) was able to directly interact with its
target channel/transporter, especially in those cases where
these transmembrane proteins possess a PY motif that
can bind the WW domains of Nedd4 proteins (eg in
ENaC, several Navs, K
+ channels and ClC5). In other
cases, such interactions may be indirect, via adapter
proteins, which themselves possess PY motifs (Fig. 4).
This has been observed earlier in yeast TM proteins that
are regulated by Rsp5, the S. Cerevisae orthologue of
Nedd4/Nedd4-2. For example, Bul1 and Bul2 serve as
adapters to connect between Rsp5 and the general amino
acid permease, Gap1, thus facilitating Rsp5-mediated
ubiquitylation of Gap1 and its subsequent endocytosis
from the PM or sorting from the Golgi to vacuoles [189].
Likewise, several arrestin related proteins (ARTs) were
recently identified as PY motif-containing adapters that
connect between Rsp5 and numerous PM proteins (mostly
transporters), thus promoting Rsp5-mediated ubiquityla-
tion and endocytosis of these proteins [122]; for reasons
not yet clear, the adapter proteins themselves are target for
Rsp5-mediated ubiquitylation [73, 122], which is required
for their function. An interesting example, also conserved
in mammals, is the adapter Bsd2. One function of this ER
protein is to regulate ubiquitin-mediated trafficking to the
PM of the metal ion transporters, Smf1 and Smf2, in yeast
[124]. The mammalian homologues of Bsd2 are Ndfip1
(N4WBP5) and Ndfip2 (MDWBP5a), and are PY motif-
containing adapters for Nedd4 proteins that reside in
intracellular vesicles. Similar to Bsd2 in yeast, they serve
as adapters to connect between WWP2 and the divalent
metal transporter DMT1 in mammals [59]. DMT1 is
responsible for iron uptake in enterocytes and its release
from vesicles in hepatocytes. Ndfip1&2 facilitate ubiq-
uitylation of DMT1 by WWP2, resulting in degradation of
this metal transporter (Fig. 4A). Accordingly, knockout of
Ndfip1 in mice leads to increased DMT1 activity and
hepatic iron accumulation [59], suggesting a key role for
this adapter in regulating iron homeostasis. More recently,
Ndfip1 was shown to protect human neurons from iron
and cobalt toxicity, and knockdown or knockout of this
adapter resulted in accumulation of these metals in
neurons [83]; In this case, Nfdip1 serves as an adapter to
connect neuronal DMT1 to Nedd4-2.
As indicated above, the vasopressin-inducible DUB,
Usp-10, enhances ENaC abundance and function at the
plasma membrane [23]. Here, however, Usp10 does not
directly de-ubiquitylate ENaC, but rather a third partner,
sorting nexin 3 (SNX3), a protein that when co-expressed
with ENaC increases cell-surface stability of the channel.
Thus, Usp-10 mediated de-ubiquitylation of SNX3 leads to
increased stability of SNX3, which in turn promotes ENaC
stabilization [23]. (Fig. 4B).
ASIC, the acid—sensing ion channel that is expressed
in neurons, belongs to the ENaC/degenerin family, but
lacks the C-terminal region present in ENaC that
contains a PY motif (and thus does not interact with
Nedd4-2). Instead, ASIC binds PICK1, a PDZ—contain-
ing protein that normally potentiates ASIC function
following PKC stimulation. PICK1 is a substrate for
Parkin, a RING finger E3 ligase, which mono-ubiquitylates
PICK1; this mono-ubiquitylation (and thus protection from
proteasomal degradation) appears to block the ability of
PICK1 to potentiate ASIC [96] (Fig. 4C). In accord, loss
of parkin in hippocampal neurons by its knockout in mice
leads to enhanced ASIC activation, thus potentially
promoting neuro-degeneration, as seen in Parkinson's
disease [96].
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Regulation of ion channels by UBLs (SUMO)
As indicated in the “Introduction” section, posttranslational
modification by UBLs has emerged as an important factor
in the regulation of function of numerous cellular proteins.
One of the better-studied UBLs is SUMO. Several recent
studies have focused on the role of SUMOylation in
regulating ion channels.
The Ca2+ channel TRPM4, expressed in cardiac Purkinje
fibers, was recently demonstrated to harbor a mutation,
E17K, which is associated with progressive familial heart
block type I (PFHB1), an autosomal dominant disease; the
mutant channel exhibits an increased channel SUMOylation
and accumulation at the plasma membrane, leading to
enhanced function of this channel [110]. It was proposed
that such enhanced SUMOylation prevents channel ubiq-
uitylation and endocytosis, although this hypothesis was
not experimentally tested (i.e., ubiquitylation of the mutant
vs. WT channel was not investigated).
Several K+ channels were also reported to be regulated
by SUMOylation. The K2P1 (TWIK1) leak channel was
previously shown to be a weak (or inactive) channel [70,
113, 148]. A report by Goldstein and colleagues then
demonstrated that this channel is maintained in an inactive
state by SUMOylation on one specific Lys (K274); upon
de-SUMOylation by SENP-1, the channel becomes active,
exhibiting K+ selectivity and sensitivity to extracellular pH
[161]. A subsequent paper challenged these findings,
suggesting that the K274 residue may not be involved in
SUMOylation of the channel [56]. Recently it has been
shown that one SUMO is sufficient to silence the K2P1
channel [157]. More recently, other studies provided
evidence for SUMO modification of other K+ channels.
Kv1.5, which mediates the I(kur) depolarizing current in
human atrial myocytes, was shown to be directly SUMOy-
lated by Ubc9 (the E2 for SUMOylation reaction) at two
sites [11]; removal of this SUMO conjugation by SENP2 or
by mutating the SUMOylation sites led to hyperpolarizing
shift in voltage dependence of steady-state inactivation of
the channel. The voltage-dependent channel Kv2.1 regu-
lates pancreatic beta cell excitability and insulin secretion.
Recent work demonstrated that SUMOylation of Kv1.5
inhibits its native current by accelerating channel inactiva-
tion and inhibiting recovery from inactivation, resulting in
decreased firing frequency [40]. These effects were aug-
mented by overexpression of Ubc9 and alleviated by
SENP1. It remains to be investigated how exactly (by what
mechanisms) does SUMOylation of K+ channels, such as
Kv1.5 or Kv2.1, regulate their biophysical properties and
activity.
It is curious that KChAP, which was originally described
as a chaperone that increases protein expression of several
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Fig. 4 Role of adapter proteins in ubiquitin-mediated regulation of
ion transporters or channels. A The metal ion transporter DMT1 is
targeted to the plasma membrane PM via recycling endosomes. This
delivery can be inhibited by the WWP2, which is recruited to DMT1
at the Golgi via the adapter proteins Ndfip1/2 (that possess PY
motifs), leading to ubiquitylation of the transporter and its degradation
by the lysosome and/or proteasome. B The vasopressin-sensitive
DUB, Usp10, de-ubiquitylates sorting nexin 3 (SNX3), a process that
stabilizes SNX3. SNX3, in turn, leads to increased stabilization of
ENaC at the plasma membrane. C PKC-stimulated potentiation of
ASIC function mediated by PICK1 (left panel) is inhibited by mono-
ubiquitylation of PICK1 by Parkin (right panel). U ubiquitin
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K+ channels, was later identified as PIAS3β, a SUMO E3
ligase [158]. So far it is not known if/how SUMOylation
may affect the chaperone activity of KChAP/PIAS3β
towards these channels.
Thus, relative to ubiquitylation of ion channels, much
less is known about the mechanisms by which SUMOyla-
tion regulates function of such channels, nor is it known
(yet) whether modifications by other UBLs can affect ion
channel function.
Summary/perspectives
Over the past 15 years much has been learned about the
role of the ubiquitin system in regulating ion channels and
transporters, particularly during their processing in the ER
and during endocytosis or sorting to MVBs and the
lysosome. Much of the work has focused on the Nedd4
family of E3 ligases, and more recently on other E3 ligases,
DUBs and several adapter proteins. In spite of these great
advances, there are critical outstanding issues that need to
be addressed:
(a) To date, many studies demonstrating regulation of
endocytosis of ion channels and transporters by E3s,
especially Nedd4 family members, have been carried
out by overexpression in Xenopus oocytes or tissue
culture cells. It is essential that these initial studies are
validated in vivo in the relevant physiological tissues.
In that regard, recent advances in studying the role of
Nedd4-2 in regulating ENaC in mouse kidney (and
lung) represent important advances, and hopefully will
be followed by similar studies on other ion channels/
transporters.
(b) So far, in most studies the nature of the ubiquitin
attachments to the ion channels/transporter, especially
at the plasma membrane, is not clear. For example, are
the channels/transporters mono-, oligo- or poly ubiq-
uitylated? Are the ubiquitins attached utilize K63, K48
(or others) linkages? Accordingly, is the cargo chan-
nel/transporter targeted to the lysosome, proteasome or
both? Likewise, very little is known about the
functions of UBLs in regulating ion transport, nor
the role of other modifications, such as acetylation.
(c) As detailed in the review, there are numerous diseases
that are associated with malfunction of some of the ion
channels described, including defects that involve the
ubiquitin system. To develop drugs that targets these
defects, it would be useful to solve the structure of the E3
ligase involved in complex with their cognate channel/
transporter, or at least the binding interface of these
binding partners. Given the recent advances in solving
structures of transmembrane proteins, this difficult task
may now become a reality. Such an approach could lead
to the development of compounds that block or enhance
these interactions in a specific manner, which could have
an important therapeutic value.
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